Pharmacokinetics and safety of single intravenous and oral doses of Dolasetron mesylate in healthy women. - Keung,A.C.; Landriault,H.; Lefebvre,M.; Gossard,D.; Dempsey,E.E.; Juneau,M.; Dimmitt,D.; Castles,M.; Roberts,L.; Spenard,J. (Biopharm Drug Dispos, 1997)